Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 7, 2000, Pages 1745-1752

  Ruef, Johannes ^a   Liu, Si Qi ^c,d   Bode, Christoph ^a   Tocchi, Monica ^b   Srivastava, Sanjay ^c,d   Runge, Marschall S ^b   Bhatnagar, Aruni ^c,d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b University of Texas Medical Branch School of Medicine   (United States)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Aldose reductase; Growth factors; Lipid peroxidation; Restenosis; Vascular smooth muscle

Indexed keywords

4 HYDROXYNONENAL; ALDEHYDE REDUCTASE; BASIC FIBROBLAST GROWTH FACTOR; CELL DNA; GLUTATHIONE DERIVATIVE; MESSENGER RNA; SORBINIL; THROMBIN; TOLRESTAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME MECHANISM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SERUM; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0033927563     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.7.1745     Document Type: Article

References (36)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. Lab Invest. 1983;49:327-333.
3. Lander HM. An essential role for free radicals and derived species in signal transduction. FASEB J. 1997;11:118-124.
4. Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation. 1997;96:3264-3265.
5. 2 for platelet-derived growth factor signal transduction. Science. 1995;270:296-299.
6. Patterson C, Ruef J, Madamanchi NR, Barry-Lane P, Hu Z, Horaist C, Ballinger CA, Brasier A, Bode C, Runge MS. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin: evidence that p47phox may participate in forming this oxidase in vitro and in vivo. J Biol Chem. 1999;274:19814-19822.
7. Harrison DG. Endothelial function and oxidant stress. Clin Cardiol. 1997;20(suppl II):11-17.
8. Ruef J, Peter K, Nordt TK, Runge MS, Kübler W, Bode C. Oxidative stress and atherosclerosis: its relationship to growth factors, thrombus formation and therapeutic approaches. Thromb Haemost. 1999;82[suppl 1]:32-37.
9. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11:81-128.
10. Ruef J, Hu ZY, Yin L-Y, Wu Y, Hanson SR, Kelly AB, Harker LA, Rao GN, Runge MS, Patterson C. Induction of vascular endothelial growth factor in balloon-injured baboon arteries: a novel role for reactive oxygen species in atherosclerosis. Circ Res. 1997;81:24-33.
11. Ruef J, Rao GN, Li F, Bode C, Patterson C, Bhatnagar A, Runge MS. Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxynonenal. Circulation. 1998;97:1071-1078.
12. Srivastava S, Chandra A, Wang L-F, Seifert WE, DaGue BB, Ansari NH, Srivastava SK, Bhatnagar A. Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart. J Biol Chem. 1998;273:10893-10900.
13. Spycher SE, Tabataba-Vakili T, O'Donnell VB, Paloma L, Azzi A. Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells. FASEB J. 1997;11:181-188.
14. Rittner HL, Hafner V, Klimiuk PA, Szweda LI, Goronzy JJ, Weyand CM. Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J Clin Invest. 1999;103:1007-1013.
15. Bhatnagar A, Srivastava SK. Aldose reductase: congenial and injurious profiles of an enigmatic enzyme. Biochem Med Metab Biol. 1992;48: 91-121.
16. Jez JM, Bennett MJ, Schlegel BP, Lewis M, Penning TM. Comparative anatomy of the aldo-keto reductase superfamily. Biochem J. 1997;326: 625-636.
17. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol Rev. 1998; 50:21-33.
18. Srivastava S, Chandra A, Ansari NH, Srivastava SK, Bhatnagar A. Identification of cardiac oxidoreductase(s) involved in the metabolism of the lipid peroxidation-derived aldehyde-4-hydroxynonenal. Biochem J. 1998; 329:469-475.
19. Srivastava S, Watowich SJ, Petrash JM, Srivastava SK, Bhatnagar A. Structural and kinetic determinants of aldehyde reduction catalyzed by aldose reductase. Biochemistry. 1999;38:42-54.
20. Donohue PJ, Alberts GF, Hampton BS, Winkles JA. A delayed-early gene activated by fibroblast growth factor-1 encodes a protein related to aldose reductase. J Biol Chem. 1994;269:8604-8609.
21. Srivastava S, Harter TM, Chandra A, Bhatnagar A, Srivastava SK, Petrash JM. Kinetic studies of FR-1, a growth factor-inducible aldo-keto reductase. Biochemistry. 1998;37:12909-12917.
22. Zeindl-Eberhart E, Jungblut PR, Otto A, Rabes HM. Identification of tumor-associated protein variants during rat hepatocarcinogenesis: aldose reductase. J Biol Chem. 1994;269:14589-14594.
23. Srivastava SK, Ansari NH, Hair GA, Das B. Aldose and aldehyde reductases in human tissues. Biochim Biophys Acta. 1984;800:220-227.
24. Ruef J, Meshel A, Hu Z, Horaist C, Ballinger CA, Thompson LJ, Subbarao VD, Dumont JA, Patterson C. Flavopiridol inhibits smooth muscle cell proliferation in vitro and neointimal formation in vivo after carotid injury in the rat. Circulation. 1999;100:659-665.
25. Sarges R, Schur RC, Belletire JL, Peterson MJ. Spiro hydantoin aldose reductase inhibitors. J Med Chem. 1988;31:230-243.
26. Hsu DKW, Guo Y, Peifley KA, Winkles JA. Differential control of murine aldose reductase and fibroblast growth factor (FGF)-regulated-1 gene expression in NIH 3T3 cells by FGF-1 treatment and hyperosmotic stress. Biochem J. 1997;328:593-598.
27. Jacquin-Becker, C, Labourdette G. Regulation of aldose reductase expression in rat astrocytes in culture. Glia. 1997;20:135-144.
28. Zeindl-Eberhart E, Jungblut PR, Otto A, Kerler R, Rabes HM. Further characterization of a rat hepatoma-derived aldose-reductase-like protein: organ distribution and modulation in vitro. Eur J Biochem. 1997;247: 792-800.
29. Peek R, McAvoy JW, Lubsen NH, Schoenmakers JG. Rise and fall of crystalline gene messenger levels during fibroblast growth factor induced terminal differentiation of lens cells. Dev Biol. 1992;152:152-160.
30. Bekhor I, Shi S, Carper D, Nishimura C, Unakar NJ. Relative abundance of aldose reductase mRNA in rat lens undergoing development of osmotic cataracts. Curr Eye Res. 1989;8:1299-1308.
31. Ludvigson MA, Sorenson RL. Immunohistochemical localization of aldose reductase. Diabetes. 1980;29:438-449.
32. Spycher S, Tabataba-Vakili S, O'Donnell VB, Paloma L, Azzi A. 4-Hydroxy-2,3-trans-nonenal induces transcription and expression of aldose reductase. Biochem Biophvs Res Commun. 1996;226:512-516.
33. Iwata T, Sato S, Jimenez J, McGowan M, Moroni M, Dey A, Ibaraki N, Reddy VN, Carper D. Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor-α. J Biol Chem. 1999;274:7993-8001.
34. 2 stimulon in Saccharomyces cerevisiae. J Biol Chem. 1998;273:22480-22489.
35. Daoudal S, Tournaire C, Halere A, Veyssiere G, Jean C. Isolation of the mouse aldose reductase promoter and identification of a tonicity-responsive element. J Biol Chem. 1997;272:2615-2619.
36. Gibbons GH, Dzau VJ. Molecular therapies for vascular diseases. Science. 1996;272:689-693.